Defending NuFlow Technologies U.S.A. in patent litigation involving UV technology to cure resins for pipe repair.
Represented Planner 5D in copyright and trade secret lawsuit alleging unauthorized acquisition and use of 3D models for artificial intelligence training. The case settled on confidential terms.
Representing high net worth family in corporate governance and breach of contract and fiduciary duties dispute with general partner of high value real estate-holding entities.
Obtained complete dismissal of trade secret misappropriation claims against Uber in which plaintiff claimed to have invented the technology behind Uber’s application platform.
Defended founder and former CEO of a genomic expression diagnostic for coronary artery disease in a Medicare reimbursement claim under the False Claims Act. The case settled on confidential terms.
Represented Penumbra in Covidien’s Opposition to Penumbra’s trademark application for its endoscopic brain surgery system. The case settled on confidential terms.
Defended Mr. Park against trade secret misappropriation claims related to plasma dry etching process to create photomasks. The case settled on confidential terms.
Successfully prosecuted a patent infringement case against nationwide retailer Frontgate concerning foldable Christmas trees.
Represented LD Products in a multi-patent, multi-product case regarding “clone” and “remanufactured” printer cartridges. The case settled on confidential terms.
Represented Rovi in multi-patent matter involving consumer-electronic guide technologies. The matters settled on confidential terms.
Represented Union Bank in multi-patent case (and related indemnification claims) related to methods of encrypting and authenticating Internet communications. The case settled on confidential terms.
Represented Fortinet in a Lear challenge contesting validity and enforceability of two patents licensed from Trend Micro related to data security. The case settled on confidential terms.
Represented Genentech in interference proceeding regarding the rights to fundamental recombinant DNAtechnology. The matter was resolved by settlement, and Genentech was issued a patent.
Defended large biotechnology company in confidential arbitration concerning recombinant human protein brought by pharmaceutical company seeking hundreds of millions of dollars for claims of misappropriated trade secrets and patent infringement under the laws of four different countries. The arbitral tribunal unanimously denied all trade secret and patent infringement claims.